128 related articles for article (PubMed ID: 16619544)
41. Clinical and immunohistochemical prognostic factors in adult glioblastoma patients.
Umesh S; Tandon A; Santosh V; Anandh B; Sampath S; Chandramouli BA; Sastry Kolluri VR
Clin Neuropathol; 2009; 28(5):362-72. PubMed ID: 19788052
[TBL] [Abstract][Full Text] [Related]
42. Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer.
Okuda K; Sasaki H; Dumontet C; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
Lung Cancer; 2008 Oct; 62(1):105-12. PubMed ID: 18395930
[TBL] [Abstract][Full Text] [Related]
43. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
Viana-Pereira M; Lopes JM; Little S; Milanezi F; Basto D; Pardal F; Jones C; Reis RM
Anticancer Res; 2008; 28(2A):913-20. PubMed ID: 18507036
[TBL] [Abstract][Full Text] [Related]
44. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y
World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326
[TBL] [Abstract][Full Text] [Related]
45. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
[TBL] [Abstract][Full Text] [Related]
46. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
Beauchesne PD; Taillandier L; Bernier V; Carnin C
Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
[TBL] [Abstract][Full Text] [Related]
47. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
Sonobe M; Nakagawa M; Takenaka K; Katakura H; Adachi M; Yanagihara K; Otake Y; Wada H; Tanaka F
J Surg Oncol; 2007 Jan; 95(1):63-9. PubMed ID: 17192868
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: no significant correlations with clinicopathological variables and treatment outcomes.
Fang FM; Li CF; Chien CY; Rau KM; Huang HY
Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):447-55. PubMed ID: 17208308
[TBL] [Abstract][Full Text] [Related]
49. Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma.
Nieder C; Astner ST; Mehta MP; Grosu AL; Molls M
Am J Clin Oncol; 2008 Jun; 31(3):300-5. PubMed ID: 18525311
[TBL] [Abstract][Full Text] [Related]
50. The natural history of EGFR and EGFRvIII in glioblastoma patients.
Heimberger AB; Suki D; Yang D; Shi W; Aldape K
J Transl Med; 2005 Oct; 3():38. PubMed ID: 16236164
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer.
Matsubara J; Yamada Y; Nakajima TE; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Oncology; 2008; 74(1-2):76-83. PubMed ID: 18544998
[TBL] [Abstract][Full Text] [Related]
52. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical tenascin-C expression in paediatric supratentorial glioblastoma multiforme.
Germanò A; Galatioto S; Caffo M; Caruso G; La Torre D; Cardia E; Tomasello F
Childs Nerv Syst; 2000 Jun; 16(6):357-62. PubMed ID: 10933231
[TBL] [Abstract][Full Text] [Related]
54. [A case of primary cerebellar glioblastoma in childhood].
Endo H; Kumabe T; Kon H; Yoshimoto T; Nakasato Y
No Shinkei Geka; 2002 Dec; 30(12):1325-9. PubMed ID: 12491584
[TBL] [Abstract][Full Text] [Related]
55. Radiation-induced cerebellar glioblastoma at the site of a treated medulloblastoma: case report.
Yang SY; Wang KC; Cho BK; Kim YY; Lim SY; Park SH; Kim IH; Kim SK
J Neurosurg; 2005 May; 102(4 Suppl):417-22. PubMed ID: 15926395
[TBL] [Abstract][Full Text] [Related]
56. The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma.
Kim B; Myung JK; Seo JH; Park CK; Paek SH; Kim DG; Jung HW; Park SH
J Neurol Sci; 2010 Jul; 294(1-2):112-8. PubMed ID: 20441994
[TBL] [Abstract][Full Text] [Related]
57. Long-term survival in cerebellar glioblastoma multiforme. Case report.
Hernandez-Gonzalez G; Marchione P; De Angelis F; Giannone C; Kouleridou A; Spallone A
J Neurosurg Sci; 2012 Dec; 56(4):379-81. PubMed ID: 23111300
[TBL] [Abstract][Full Text] [Related]
58. EGFR overexpression and radiation response in glioblastoma multiforme.
Barker FG; Simmons ML; Chang SM; Prados MD; Larson DA; Sneed PK; Wara WM; Berger MS; Chen P; Israel MA; Aldape KD
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):410-8. PubMed ID: 11567815
[TBL] [Abstract][Full Text] [Related]
59. Clinical and survival covariates of eight classes of childhood supratentorial neuroglial tumors.
Gilles FH; Leviton A; Tavaré CJ; Adelman L; Rorke LB; Sobel EL; Hedley-Whyte ET; Davis RL
Cancer; 2002 Sep; 95(6):1302-10. PubMed ID: 12216099
[TBL] [Abstract][Full Text] [Related]
60. Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform.
Lynch JC; Welling L; Escosteguy C; Pereira AG; Andrade R; Pereira C
Br J Neurosurg; 2013 Feb; 27(1):80-3. PubMed ID: 22900509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
